Introduction Triple-negative breast cancer (TNBC) cases comprise approximately 15% of newly diagnosed breast cancers and are associated with poor prognosis and limited treatment options. In this retrospective study from South Wales, 81 patients with breast cancer found to be ER, PR and HER2 negative were reviewed to determine whether there are common imaging and pathological fi ndings. Methods Patients identifi ed from pathological databases at two hospitals included symptomatic and screening cases. Clinical records were reviewed to determine age at diagnosis, family history and clinical fi ndings; pathological reports to identify size, grade, type and nodal status; and imaging studies to determine breast density, lesion type, classifi cation and size. Results Eighty per cent of patients were aged over 50 years (range 50 to 89 years). Nineteen per cent reported a family history. Eighty-nine per cent were grade 3 tumours, 89% were ductal type of which 30% had associated DCIS. The majority were large tumours (78% over 20 mm). Fifty-two per cent were node positive (20% had more than four nodes positive). Thirtynine per cent had associated vascular invasion. Calcifi cation was a dominant mammographic feature (37%), 28% had well-defi ned masses. Conclusions Previous studies have found well-defi ned masses to be a dominant imaging feature but this study has found malignant calcifi cation to be more common. The tumours were mainly large and frequently associated with vascular invasion, possibly contributing to the poor prognosis despite being node negative in nearly one-half of the cases. There appears to be an association with family history and to be common in the over 50s, contrary to current thinking. A national prospectively collected database TNBC could aid understanding of this group. Introduction During the changeover from analogue to digital screening in the UK, reassurance is needed to confi rm that the outcomes with digital are equal to or better than analogue screening. Methods Warwickshire, Solihull & Coventry Breast Screening Service commenced the phased conversion to digital screening in 2005, with a single digital machine on one of three mobiles. This retrospective study compares the screening outcomes of 138,173 women aged between 49 and 70 years screened on analogue or digital imaging between April 2005 and March 2009 inclusive. Approximately one-third of these were screened using digital, the remainder on analogue.
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Results
The results show no diff erence in the rates of screen-detected cancer in prevalent or incident groups between analogue and digital, and rates were stable with time. Similar proportions of invasive and non-invasive cancers were detected in both groups and tumour size was not signifi cantly diff erent. No signifi cant increase in cancer detection in younger compared with older women was seen in the digital group, and digital did not diagnose a higher proportion of lobular cancers. No diff erence in interval cancer rates between the two methods of screening was seen. On radiological subclassifi cation of interval cancers into normal/benign, uncertain and suspicious, signifi cantly fewer interval cancers were classifi ed as uncertain in the digital than the analogue screening group. See Table 1 .
Conclusions These results are reassuring that digital diagnoses similar cancers to analogue screening, and suggest that digital may allow more defi nitive interval cancer classifi cation.
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Variability in fi lm reader estimates of breast density in the PERFORMS scheme IT Darker, AG Gale, Y Chen Loughborough University, Loughborough, UK Breast Cancer Research 2010, 12(Suppl 3):P42 (doi: 10.1186/bcr2695) Introduction All UK screening personnel are invited to take part annually in the PERFORMS self-assessment scheme where they make several judgements about series of challenging recent screening cases. As part of this process they assess the density of each case. Density is a factor known to be associated with a greater risk of developing breast cancer and thus accurate density judgements may well presage the facility to proff er improved follow-up for individual women. The present study examines the degree of variability amongst fi lm reader estimates of breast density on a large number of cases. Methods Data were examined from the most recent 2 years of the PERFORMS scheme where breast density estimates were made for each case examined using a three-point rating scale of fatty, mixed density, and dense. These data comprised information from 444 individuals (mainly consultant radiologists, advanced practitioners and breast physicians) who had all examined the same 240 diffi cult cases. Results The inter-rater reliability, corrected for chance agreements, was assessed using kappa. Overall, the degree of agreement across cases on breast density category was signifi cantly greater than no agreement (P <0.0001). However, only a moderate degree of inter-rater reliability was exhibited, κ = 0.470. There were signifi cant diff erences between the levels of agreement amongst the ratings of the radiologists, advanced practitioners and others (all P <0.05).
Conclusions The low agreement rates between participants for density ratings were surprising. That there were diff erences between the occupational groupings may refl ect breast screening experience.
Introduction
The prevalent round recall rate is higher than the incident recall rate. Implementation of age extension will lead to two prevalent rounds and with this increased clinical and fi nancial pressure on screening units. Any processes that help reduce the recall rate will be of benefi t to screening units. Methods Retrospective data were collected from April 2008 to March 2009 of prevalent round ladies recalled to assessment clinics. The data recorded included reason for recall, imaging fi ndings and needle test results. Results A total of 7,627 women were invited for screening in April 2008 to March 2009, of which 5,341 attended. Four hundred and eighty-one ladies were recalled to assessment; 451/481 of the packets available were reviewed. Forty cancers were identifi ed in 39 patients. All cases of malignancy were coded as RU, RS or RM at the time of fi lm reading. Thirty-two patients were recalled for both sides, four patients recalled for two lesions within the same breast. Nineteen patients were clinical recalls (BA). All solitary RB masses thought to be benign at the time of fi lm reading proved to be benign (91/215 masses). Ten cases recalled for bilateral RB masses were benign. Thirty-six out of 140 asymmetries thought to be benign at the time of fi lm reading were benign.
Conclusions The recall rate may be reduced in the prevalent round by not recalling solitary RB masses, bilateral RB masses, and asymmetry that appears physiological/benign on two views. In this unit this would have reduced the recall rate without adversely aff ecting the cancer detection rate. Introduction Imaging alone cannot reliably distinguish benign/malignant breast disease or assess the extent of cancer. This study assesses the feasibility of using additional information obtained at US (BHS) to aid diagnosis and preoperative assessment. Methods 3D US scans at 8 MHz, 12 MHz, 15 MHz were obtained of breast tissue in normal volunteers in two planes and with/without harmonics. Five volumes of sagittal scans at 8 MHz from three individuals were used to identify normal characteristics and defi ne the baseline. The 3D volume was divided into voxels (0.1 x 2 x 1.5 mm) and raw data from each voxel were analysed by applying linear and nonlinear classifi ers to assess 29 statistical characteristics (BHS). The training dataset contained 300,000 voxels. After training, the classifi er's output showed 3% error on both normal and abnormal tissue. The algorithm was tested on 32 further volumes representing 6,000,000 voxels of normal and abnormal tissue from 20 individuals. Abnormal tissue included various biopsy-proven lesions: malignancy (six), papilloma (one), hamartoma (one), fi broadenoma (two), cyst (two), fi brosis (one). Subclassifi ers were developed to distinguish between cancer and benign voxels.
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Results In 17 normal testing volumes, 3% of isolated voxels were classifi ed as abnormal. In 15 abnormal testing volumes, the subclassifi ers diff erentiated between malignant and benign tissue. BHS in benign tissue showed <1% abnormal voxels in cyst, hamartoma, papilloma and benign fi brosis. The fi broadenomas diff ered showing <5% and <24% abnormal voxels. Abnormal voxels in cancers increased with the volume of cancer at pathology. Conclusions Histoscanning reliably discriminated normal from abnormal tissue and could distinguish between benign and malignant lesions.
